Target intelligence / Profile preview

PARP11 antisense RNA 1 (PARP11-AS1)

Target: PARP11-AS1
Molecular classification: Other (Long non-coding RNA, lncRNA)

Overview

PARP11 antisense RNA 1 (PARP11-AS1) is a long non-coding RNA (lncRNA) that is transcribed in the antisense direction relative to the PARP11 gene. Its primary presumed function is the regulation of PARP11 expression at the transcriptional or post-transcriptional level, likely through RNA interference or chromatin modification mechanisms typical of antisense lncRNAs. There is currently no evidence supporting a direct role for PARP11-AS1 as a traditional therapeutic target, receptor, enzyme, or transporter. No clinically relevant drugs, disease roles, or biomarker applications have been reported for this molecule.

Other names: PARP11-AS1

Biological functions

Regulation of gene expression (specifically regulation of PARP11)

Beyond the preview

Go deeper on PARP11 antisense RNA 1 (PARP11-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PARP11 antisense RNA 1 (PARP11-AS1).

Explore the full profile